Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen

At the age of 83, a woman presented with an extremely rare cancer, basal cell adenocarcinoma (BCAC) of the supraglottic larynx. Pathology revealed a stage IVA tumor, pathological stage T4N0M0. She was treated with surgery and did not receive any adjuvant chemotherapy or radiation therapy. At the age...

Full description

Bibliographic Details
Main Authors: Glen J. Weiss, Patrick J. Donovan, Christopher H. Bailey
Format: Article
Language:English
Published: SAGE Publishing 2011-10-01
Series:Rare Tumors
Subjects:
Online Access:http://www.pagepress.org/journals/index.php/rt/article/view/2308